These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 27895584

  • 1. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
    Zhou Y, He Z, Gao Y, Zheng R, Zhang X, Zhao L, Tan M.
    Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
    [Abstract] [Full Text] [Related]

  • 2. GHK Peptide Inhibits Bleomycin-Induced Pulmonary Fibrosis in Mice by Suppressing TGFβ1/Smad-Mediated Epithelial-to-Mesenchymal Transition.
    Zhou XM, Wang GL, Wang XB, Liu L, Zhang Q, Yin Y, Wang QY, Kang J, Hou G.
    Front Pharmacol; 2017; 8():904. PubMed ID: 29311918
    [Abstract] [Full Text] [Related]

  • 3. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
    Tang H, He H, Ji H, Gao L, Mao J, Liu J, Lin H, Wu T.
    J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
    [Abstract] [Full Text] [Related]

  • 4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY, Kim DY, Yoon JY, Son ES, Kim YJ, Park JW, Jeong SH.
    BMC Pharmacol Toxicol; 2018 Apr 02; 19(1):13. PubMed ID: 29609658
    [Abstract] [Full Text] [Related]

  • 5. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
    Dong XW, Jia YL, Ge LT, Jiang B, Jiang JX, Shen J, Jin YC, Guan Y, Sun Y, Xie QM.
    Toxicology; 2017 Aug 15; 389():31-41. PubMed ID: 28694203
    [Abstract] [Full Text] [Related]

  • 6. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
    Gao L, Jiang D, Geng J, Dong R, Dai H.
    Exp Physiol; 2019 Dec 15; 104(12):1942-1951. PubMed ID: 31535412
    [Abstract] [Full Text] [Related]

  • 7. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
    Hao W, Yu TT, Zuo DZ, Hu HZ, Zhou PP.
    Exp Lung Res; 2023 Nov 20; 49(1):205-219. PubMed ID: 38044666
    [Abstract] [Full Text] [Related]

  • 8. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.
    Tang H, Gao L, Mao J, He H, Liu J, Cai X, Lin H, Wu T.
    Cell Stress Chaperones; 2016 Mar 20; 21(2):239-49. PubMed ID: 26577463
    [Abstract] [Full Text] [Related]

  • 9. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
    Li SR, Tan ZX, Chen YH, Hu B, Zhang C, Wang H, Zhao H, Xu DX.
    Respir Res; 2019 Nov 27; 20(1):266. PubMed ID: 31775746
    [Abstract] [Full Text] [Related]

  • 10. [Aqueous extract of Epimedium sagittatum mitigates pulmonary fibrosis in mice].
    Wang R, Hou FY, Zeng MN, Zhang BB, Zhang QQ, Xie SS, Feng WS, Zheng XK.
    Zhongguo Zhong Yao Za Zhi; 2023 Oct 27; 48(20):5612-5622. PubMed ID: 38114154
    [Abstract] [Full Text] [Related]

  • 11. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
    Tang J, Ke J, Fu Y, He XW, Li XW.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov 27; 37(6):577-583. PubMed ID: 34821087
    [Abstract] [Full Text] [Related]

  • 12. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 27; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

  • 13. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
    Jia L, Sun P, Gao H, Shen J, Gao Y, Meng C, Fu S, Yao H, Zhang G.
    J Pharm Pharmacol; 2019 Jun 27; 71(6):1017-1028. PubMed ID: 30847938
    [Abstract] [Full Text] [Related]

  • 14. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
    Qian W, Cai X, Qian Q, Zhang W, Wang D.
    J Cell Mol Med; 2018 Sep 27; 22(9):4354-4365. PubMed ID: 29971947
    [Abstract] [Full Text] [Related]

  • 15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.
    J Pharmacol Exp Ther; 2015 Sep 27; 354(3):302-9. PubMed ID: 26126535
    [Abstract] [Full Text] [Related]

  • 16. Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
    Ding D, Shen X, Yu L, Zheng Y, Liu Y, Wang W, Liu L, Zhao Z, Nian S, Liu L.
    Phytother Res; 2023 Jul 27; 37(7):2787-2799. PubMed ID: 36807664
    [Abstract] [Full Text] [Related]

  • 17. Urine-Derived Stem Cells Reverse Bleomycin‑Induced Experimental Pulmonary Fibrosis by Inhibition of the TGF-β1-Smad2/3 Pathway.
    Zhang Y, Xia Y, Zhang R, Zhou X, Jiang J.
    Cytotherapy; 2024 Oct 27; 26(10):1236-1244. PubMed ID: 38852093
    [Abstract] [Full Text] [Related]

  • 18. Oxymatrine attenuates bleomycin-induced pulmonary fibrosis in mice via the inhibition of inducible nitric oxide synthase expression and the TGF-β/Smad signaling pathway.
    Liu L, Lu W, Ma Z, Li Z.
    Int J Mol Med; 2012 May 27; 29(5):815-22. PubMed ID: 22367596
    [Abstract] [Full Text] [Related]

  • 19. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB, Gourishetti K, Tirunavalli SK, Shaikh TB, Sistla R.
    Phytomedicine; 2020 Nov 27; 78():153298. PubMed ID: 32781391
    [Abstract] [Full Text] [Related]

  • 20. Induced pluripotent stem cell-derived mesenchymal stem cells reverse bleomycin-induced pulmonary fibrosis and related lung stiffness.
    Chakraborty A, Wang C, Hodgson-Garms M, Broughton BRS, Frith JE, Kelly K, Samuel CS.
    Biomed Pharmacother; 2024 Sep 27; 178():117259. PubMed ID: 39116786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.